FDAnews
www.fdanews.com/articles/72092-insite-announces-9-million-private-financing

InSite Announces $9 Million Private Financing

May 9, 2005

InSite Vision -- an ophthalmic therapeutics, diagnostics and drug-delivery company -- announced it has entered into definitive agreements for a $9 million private financing of common stock and warrants for common stock. Closing of the financing is contingent on approval from the American Stock Exchange, among other standard conditions. The terms of the agreements provide for the sale of approximately 16.4 million newly issued shares of common stock at $0.55 per share, and the issuance of warrants to purchase approximately 4.9 million shares of common stock at an exercise price of $0.6325 per share.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=237560&categoryid=36%2C61)